Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut-liver axisSTEM CELL RESEARCH & THERAPYIF7.32025-01-070OAAI
m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injuryHEPATOLOGYIF15.82023-12-124PRE
The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosisMOLECULAR THERAPYIF122022-12-0134OAAI
Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4aNATURE COMMUNICATIONSIF15.72022-08-0539OAAI
Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NE-κB signaling and glycolysisSTEM CELL RESEARCH & THERAPYIF7.32021-09-0918OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向